Literature DB >> 18456147

Cranial base growth in patients with Down syndrome: a longitudinal study.

Juan J Alio1, Jose Lorenzo, Carmen Iglesias.   

Abstract

INTRODUCTION: The purpose of this study was to assess the growth of the cranial base in a sample of patients diagnosed with Down syndrome (DS).
METHODS: The sample comprised 47 subjects (25 boys, 22 girls) with DS. All patients had at least 2 x-rays that showed the cranial base. To make comparisons among age groups, the sample was divided into 3 groups: prepubescent (8-11 years), pubescent (12-14 years), and postpubescent (15-18 years). A control group included 38 normal subjects (22 boys, 16 girls, without DS) who were part of a longitudinal growth sample. Computerized cephalometric analysis was performed on all subjects, and cephalometric superimpositions were made. Two-way ANOVA was used to study the overall changes between groups. In addition, 1-way ANOVA and the Duncan multiple range test were used to analyze possible differences in the age groups.
RESULTS: Cranial base growth in patients with DS from age 8 to 18 was similar to that of the control group. Structural differences in the cranial base are established before 8 years of age and consist of shorter, flatter anterior and posterior bases.

Entities:  

Mesh:

Year:  2008        PMID: 18456147     DOI: 10.1016/j.ajodo.2006.03.036

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  10 in total

1.  Vestiges of Ossified Spheno-occipital Suture in an Elderly Patient With Down Syndrome and Lateral Skull Base Fracture.

Authors:  Reinhard E Friedrich; Felix K Kohlrusch; Ulrich Grzyska
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Authors:  Joshua D Blazek; Anna Gaddy; Rachel Meyer; Randall J Roper; Jiliang Li
Journal:  Bone       Date:  2010-09-24       Impact factor: 4.398

3.  The Influence of trisomy 21 on facial form and variability.

Authors:  John M Starbuck; Theodore M Cole; Roger H Reeves; Joan T Richtsmeier
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

4.  Prevalence and patterns of permanent tooth agenesis in Down syndrome and their association with craniofacial morphology.

Authors:  Sunjay Suri; Bryan D Tompson; Eshetu Atenafu
Journal:  Angle Orthod       Date:  2011-03       Impact factor: 2.079

5.  Cranial base, maxillary and mandibular morphology in Down syndrome.

Authors:  Sunjay Suri; Bryan D Tompson; Lynn Cornfoot
Journal:  Angle Orthod       Date:  2010-09       Impact factor: 2.079

6.  Cranial base and maxillary changes in patients treated with Frankel' s functional regulator (1b).

Authors:  Juan-Jose Alió-Sanz; Carmen Iglesias-Conde; Jose Lorenzo-Pernía; Alejandro Iglesias-Linares; Asunción Mendoza-Mendoza; Enrique Solano-Reina
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-07-01

7.  Study of mandibular growth in patients treated with Fränkel's functional regulator (1b).

Authors:  Juan-Jose Alió-Sanz; Eyleen Kato; Jose Lorenzo-Pernía; Carmen Iglesias-Conde; Alejandro Iglesias-Linares; Enrique Solano-Reina
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-09-01

8.  A Critical Evaluation of the Down Syndrome Diagnosis for LB1, Type Specimen of Homo floresiensis.

Authors:  Karen L Baab; Peter Brown; Dean Falk; Joan T Richtsmeier; Charles F Hildebolt; Kirk Smith; William Jungers
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

9.  The Posterior Part Influences the Anterior Part of the Mouse Cranial Base Development.

Authors:  Honghao Zhang; Ke'ale W Louie; Anshul K Kulkarni; Karen Zapien-Guerra; Jingwen Yang; Yuji Mishina
Journal:  JBMR Plus       Date:  2021-12-24

10.  Craniofacial morphology in down syndrome: a systematic review and meta-analysis.

Authors:  Ascensión Vicente; Luis-Alberto Bravo-González; Ana López-Romero; Clara Serna Muñoz; Julio Sánchez-Meca
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.